T-Type Ca2+ Channel Inhibition Induces p53-Dependent Cell Growth Arrest and Apoptosis through Activation of p38-MAPK in Colon Cancer Cells

T-Type Ca2+ Channel Inhibition Induces p53-Dependent Cell Growth Arrest and Apoptosis through Activation of p38-MAPK in Colon Cancer Cells
复制标题

DOI:
10.1158/1541-7786.mcr-13-0485
复制
发表时间:
2014-03-01
影响因子:
5.2
通讯作者:
Dziegielewski, Jaroslaw
Dziegielewski, Jaroslaw
中科院分区:
医学2区
文献类型:
--
作者:
Dziegielewska, Barbara;Brautigan, David L.;Dziegielewski, Jaroslaw

文献摘要

被引文献

相似文献

上皮肿瘤细胞表达T型Ca 2+通道,其被认为促进细胞增殖。本研究探讨了细胞对小分子拮抗剂或RNAi介导的敲除抑制T型Ca 2+通道的反应。选择性T型钙通道拮抗剂在表达野生型p53(p53 wt)的HCT 116细胞中比在HCT 116突变型p53(-/-)细胞中更有效地引起生长抑制和凋亡。这些拮抗剂增加了p53依赖性基因表达,并增加了p53在特定靶序列的基因组占有率。与HCT 116突变型p53(-/-)细胞相比,在HCT 116 p53 wt细胞中敲低单个T型Ca 2+通道亚基(CACNA 1G)降低细胞生长并诱导caspase-3/7活化。此外,当p53 wt稳定表达时,不表达功能性p53的CaCo 2细胞对CACNA 1G敲低更敏感。在T型Ca ~(2+)通道抑制后,p38-MAPK促进p53 wt的Ser 392磷酸化。用抑制剂SB 203580或靶向p38-MAPK α/β(MAPK 14/MAPK 11)的特异性RNAi处理的细胞显示出对T型Ca 2+通道抑制的抗性。最后,对通道抑制的敏感性降低与p53积累减少和p53靶基因p21 Cip 1(CDKN 1A)和BCL 2结合组分3(BBC 3/CDKN 1A)表达减少有关。(C)2013年AACR。
Epithelial tumor cells express T-type Ca2+ channels, which are thought to promote cell proliferation. This study investigated the cellular response to T-type Ca2+ channel inhibition either by small-molecule antagonists or by RNAi-mediated knockdown. Selective T-type Ca2+ channel antagonists caused growth inhibition and apoptosis more effectively in HCT116 cells expressing wild-type p53 (p53wt), than in HCT116 mutant p53(-/-) cells. These antagonists increased p53-dependent gene expression and increased genomic occupancy of p53 at specific target sequences. The knockdown of a single T-type Ca2+ channel subunit (CACNA1G) reduced cell growth and induced caspase-3/7 activation in HCT116 p53wt cells as compared with HCT116 mutant p53(-/-) cells. Moreover, CaCo2 cells that do not express functional p53 were made more sensitive to CACNA1G knockdown when p53wt was stably expressed. Upon T-type Ca2+ channel inhibition, p38-MAPK promoted phosphorylation at Ser392 of p53wt. Cells treated with the inhibitor SB203580 or specific RNAi targeting p38-MAPK alpha/beta (MAPK14/MAPK11) showed resistance to T-type Ca2+ channel inhibition. Finally, the decreased sensitivity to channel inhibition was associated with decreased accumulation of p53 and decreased expression of p53 target genes, p21Cip1 (CDKN1A) and BCL2-binding component 3 (BBC3/PUMA). (C)2013 AACR.